BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
S. K. Sarin, M. Kumar, G. K. Lau, Z. Abbas, H. L. Y. Chan, C. J. Chen, D. S. Chen, H. L. Chen, P. J. Chen, R. N. Chien, A. K. Dokmeci, Ed Gane, J. L. Hou, W. Jafri, J. Jia, J. H. Kim, C. L. Lai, H. C. Lee, S. G. Lim, C. J. Liu, S. Locarnini, M. Al Mahtab, R. Mohamed, M. Omata, J. Park, T. Piratvisuth, B. C. Sharma, J. Sollano, F. S. Wang, L. Wei, M. F. Yuen, S. S. Zheng, J. H. Kao. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 updateHepatology International 2016; 10(1): 1 doi: 10.1007/s12072-015-9675-4
2
Hwai-I Yang, Mei-Hsuan Lee, Jessica Liu, Hui-Han Hu. Viral Hepatitis in Children2019; : 33 doi: 10.1007/978-981-13-0050-9_3
3
Chien-Jen Chen, Hwai-I Yang, Mei-Hsuan Lee, Jessica Liu, Hui-Han Hu. Hepatitis B Virus in Human DiseasesMolecular and Translational Medicine 2016; : 249 doi: 10.1007/978-3-319-22330-8_12
4
Hwai-I Yang, Tai-Chung Tseng, Jessica Liu, Mei-Hsuan Lee, Chun-Jen Liu, Tung-Hung Su, Richard Batrla-Utermann, Henry Lik-Yuen Chan, Jia-Horng Kao, Chien-Jen Chen. Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without CirrhosisClinical Gastroenterology and Hepatology 2016; 14(3): 461 doi: 10.1016/j.cgh.2015.10.033
5
Nicolas Goossens, Yujin Hoshida. Personalized management of hepatocellular carcinoma based on molecular information: Future prospectsClinical Liver Disease 2015; 5(6): 132 doi: 10.1002/cld.483
6
Pedro Magalhães-Costa, Luís Lebre, Paula Peixe, Sofia Santos, Cristina Chagas. Hepatocellular Carcinoma in Chronic Hepatitis B Patients on Third Generation Nucleos(t)ides Analogs: Risk Factors and Performance of a Risk ScoreGE Portuguese Journal of Gastroenterology 2016; 23(5): 233 doi: 10.1016/j.jpge.2016.02.001
7
Jessica Liu, Hui-Han Hu, Mei-Hsuan Lee, Masaaki Korenaga, Chin-Lan Jen, Richard Batrla-Utermann, Sheng-Nan Lu, Li-Yu Wang, Masashi Mizokami, Chien-Jen Chen, Hwai-I Yang. Serum Levels of M2BPGi as Short-Term Predictors of Hepatocellular Carcinoma in Untreated Chronic Hepatitis B PatientsScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-14747-5
8
Nicolas Goossens, Yujin Hoshida. Tratamiento personalizado del carcinoma hepatocelular basado en información molecular: perspectivas futurasClinical Liver Disease 2016; 8(S1): S43 doi: 10.1002/cld.601
9
Hung-Chih Yang. Hepatitis B Virus and Liver Disease2018; : 119 doi: 10.1007/978-981-10-4843-2_6
10
Hui-Han Hu, Jessica Liu, Yu-Ling Lin, Wun-Sheng Luo, Yu-Ju Chu, Chia-Lin Chang, Chin-Lan Jen, Mei-Hsuan Lee, Sheng-Nan Lu, Li-Yu Wang, San-Lin You, Hwai-I Yang, Chien-Jen Chen. The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis BGut 2016; 65(9): 1514 doi: 10.1136/gutjnl-2015-310686
11
Justin Chien, Jessica Liu, Mei-Hsuan Lee, Chin-Lan Jen, Richard Batrla-Utermann, Sheng-Nan Lu, Li-Yu Wang, San-Lin You, Hwai-I Yang, Chien-Jen Chen. Risk and predictors of hepatocellular carcinoma for chronic hepatitis B patients with newly developed cirrhosisJournal of Gastroenterology and Hepatology 2016; 31(12): 1971 doi: 10.1111/jgh.13422
12
Chien-Jen Chen, Mei-Hsuan Lee, Jessica Liu, Hwai-I Yang. Hepatocellular carcinoma risk scores: ready to use in 2015?Hepatic Oncology 2015; 2(1): 1 doi: 10.2217/hep.14.32
13
Chih-Lin Lin, Jia-Horng Kao. Perspectives and control of hepatitis B virus infection in TaiwanJournal of the Formosan Medical Association 2015; 114(10): 901 doi: 10.1016/j.jfma.2015.06.003
14
ZHICHENG YAO, KUNPENG HU, HE HUANG, SHILEI XU, QINGLIANG WANG, PENG ZHANG, PEISHENG YANG, BO LIU. shRNA-mediated silencing of the RFC3 gene suppresses hepatocellular carcinoma cell proliferationInternational Journal of Molecular Medicine 2015; 36(5): 1393 doi: 10.3892/ijmm.2015.2350
15
Josh Hanson, Melissa Fox, Adam Anderson, Penny Fox, Kate Webster, Charlie Williams, Blake Nield, Richard Bagshaw, Allison Hempenstall, Simon Smith, Norma Solomon, Peter Boyd, Yury E Khudyakov. Chronic hepatitis B in remote, tropical Australia; successes and challengesPLOS ONE 2020; 15(9): e0238719 doi: 10.1371/journal.pone.0238719
16
Sahar Amirpour-Rostami, Mohammad Kazemi Arababadi. IL-18 and IL-1β Gene Polymorphisms: The Plausible Risk Factors for Chronic Hepatitis BViral Immunology 2019; 32(5): 208 doi: 10.1089/vim.2018.0155
17
L.-Y. Mak, D. K.-H. Wong, K.-S. Cheung, W.-K. Seto, C.-L. Lai, M.-F. Yuen. Review article: hepatitis B core-related antigen (HBcrAg): an emerging marker for chronic hepatitis B virus infectionAlimentary Pharmacology & Therapeutics 2018; 47(1): 43 doi: 10.1111/apt.14376
18
Chih-Lin Lin, Tai-Chung Tseng, Jia-Horng Kao. What can we learn from hepatitis B virus clinical cohorts?Liver International 2015; 35: 91 doi: 10.1111/liv.12716